Literature DB >> 12759448

Tryptase precursors are preferentially and spontaneously released, whereas mature tryptase is retained by HMC-1 cells, Mono-Mac-6 cells, and human skin-derived mast cells.

Lawrence B Schwartz1, Hae-Ki Min, Shunlin Ren, Han-Zhang Xia, Jiang Hu, Wei Zhao, George Moxley, Yoshihiro Fukuoka.   

Abstract

Tryptase (alpha and beta) levels in serum are used to assess mast cell involvement in human disease. Using cultured cells, the current study examines the hypothesis that protryptase(s) are spontaneously secreted by mast cells at rest, whereas mature tryptase(s) are stored in secretory granules until their release by activated cells. HMC-1 cells have only beta-tryptase genes and the corresponding mRNA. Mono-Mac-6 cells have both alpha- and beta-tryptase genes but preferentially express alpha-tryptase. Mono-Mac-6 cells spontaneously secrete most of their tryptase, which consists of alpha-protryptase, whereas mature tryptase is retained inside these cells. HMC-1 cells also spontaneously secrete most of their tryptase, identified as beta-protryptase, and retain mature tryptase. Skin-derived mast cells retain most of their tryptase, which is mature, and spontaneously secrete protryptase(s). Total tryptase levels in plasma are detectable but no different in healthy subjects with and without the gene for alpha-tryptase, consistent with pro forms of both alpha- and beta-tryptase being spontaneously secreted. Thus, protryptase(s) are spontaneously secreted by resting mast cells, whereas mature tryptase is retained by mast cells until they are activated to degranulate.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12759448     DOI: 10.4049/jimmunol.170.11.5667

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  28 in total

Review 1.  Tryptase genetics and anaphylaxis.

Authors:  George H Caughey
Journal:  J Allergy Clin Immunol       Date:  2006-04-27       Impact factor: 10.793

2.  Tryptase haplotype in mastocytosis: relationship to disease variant and diagnostic utility of total tryptase levels.

Authors:  Cem Akin; Darya Soto; Erica Brittain; Adhuna Chhabra; Lawrence B Schwartz; George H Caughey; Dean D Metcalfe
Journal:  Clin Immunol       Date:  2007-04-20       Impact factor: 3.969

Review 3.  Hereditary Alpha-Tryptasemia: a Commonly Inherited Modifier of Anaphylaxis.

Authors:  Richard Wu; Jonathan J Lyons
Journal:  Curr Allergy Asthma Rep       Date:  2021-05-10       Impact factor: 4.806

4.  Tryptase is not cleared by the kidneys into the urine.

Authors:  Michael R Simon; Mindy Jan; Jerry Yee; Uday S Nori; Jiang Hu; Cem Akin; Lawrence B Schwartz
Journal:  Int Arch Allergy Immunol       Date:  2009-11-24       Impact factor: 2.749

Review 5.  Mast cell proteases as pharmacological targets.

Authors:  George H Caughey
Journal:  Eur J Pharmacol       Date:  2015-05-07       Impact factor: 4.432

6.  Promiscuous processing of human alphabeta-protryptases by cathepsins L, B, and C.

Authors:  Quang T Le; Hae-Ki Min; Han-Zhang Xia; Yoshihiro Fukuoka; Nobuhiko Katunuma; Lawrence B Schwartz
Journal:  J Immunol       Date:  2011-05-11       Impact factor: 5.422

Review 7.  Mast cell activation in the context of elevated basal serum tryptase: genetics and presentations.

Authors:  Paneez Khoury; Jonathan J Lyons
Journal:  Curr Allergy Asthma Rep       Date:  2019-11-27       Impact factor: 4.806

8.  Processing of human protryptase in mast cells involves cathepsins L, B, and C.

Authors:  Quang T Le; Gregorio Gomez; Wei Zhao; Jiang Hu; Han-Zhang Xia; Yoshihiro Fukuoka; Nobuhiko Katunuma; Lawrence B Schwartz
Journal:  J Immunol       Date:  2011-07-08       Impact factor: 5.422

9.  Assessing anaphylactic risk? Consider mast cell clonality.

Authors:  Dean D Metcalfe; Lawrence B Schwartz
Journal:  J Allergy Clin Immunol       Date:  2009-03       Impact factor: 10.793

10.  Alpha 2-macroglobulin capture allows detection of mast cell chymase in serum and creates a reservoir of angiotensin II-generating activity.

Authors:  Wilfred W Raymond; Sharon Su; Anastasia Makarova; Todd M Wilson; Melody C Carter; Dean D Metcalfe; George H Caughey
Journal:  J Immunol       Date:  2009-05-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.